Molecular Diagnostics

Biomarker Detects Active Melanoma and Predicts Survival
Melanoma is the most dangerous form of skin cancer, these cancerous growths develop when unrepaired DNA damage to skin cells, which is most often caused by ultraviolet radiation from sunshine or tanning beds, triggers mutations (genetic defects) that lead the skin cells to multiply rapidly and form malignant tumors. More...25 Jul 2018

Acute Myeloid Leukemia Risk Predicted in Healthy Individuals
The incidence of acute myeloid leukemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure. More...25 Jul 2018
Biosensor Chip Detects SNPs with Higher Sensitivity
A single nucleotide polymorphism (SNP) is the change in a single nucleotide base (A, C, G or T) in the DNA sequence and it is the most common type of genetic mutation. While most SNPs have no discernible effect on health, some are associated with increased risk of developing pathological conditions such as cancer, diabetes, heart disease, neurodegenerative disorders, autoimmune and inflammatory diseases. More...24 Jul 2018


Integrated Analyses Offer Molecular Insights to Tumor Subtypes
The most common malignancy of young adult males of European descent are testicular germ cell tumors (TGCTs) of the type derived from germ cell neoplasia in situ (GCNIS). There are two major histologic types: pure classic seminoma and nonseminomatous germ cell tumors (NSGCTs). More...19 Jul 2018

Biomarker Discovered for Hypervirulent Pathogen
There is no accurate method for distinguishing between the hypervirulent strain from the classical strain of Klebsiella pneumoniae (cKp), which is most often seen in the Western hemisphere, and is less virulent and usually causes infections in hospital settings. More...18 Jul 2018
MicroRNA Pair Serves as Biomarkers for Rapid Sepsis Diagnosis
Two microRNAs that could be the basis of a test to help physicians classify patients into those with organ failure who are at high risk of sepsis and death and those patients with milder infections have been identified. More...16 Jul 2018
In Other News
Optimization of Analytical Procedures Reduces Variability of Results
Genetic Connections Uncovered Between Psychiatric Disorders
Female Bladder Bacteria Reveal Urogenital Microbiota
Lipid Species Offer Insights into Metabolic Health
New Genre of Small-Cell Lung Cancer Discovered
Simple Test Could Reduce Treatment of Bladder Cancer
Current-Tunneling Measurements Analyze Single DNA Molecules
Variant CJD Diagnosed by Protein Misfolding Amplification
Recurrent Rearrangements Identified in Soft Tissue Tumors
DNA Code Unraveled for Rare Neurologic Disease
Measurement of Two Biomarkers Predicts Diabetes Risk
UTIs Diagnosed with Genetic Analysis of Cell-Free DNA
Gene Signatures and Biomarkers Predict RA Onset
Extracellular RNA Helps Diagnose Medical Conditions
Genomic Atlas of Human Plasma Proteome Publicized
Metagenomics Uncover Pathogens and Drug-Resistance Genes
Biomarker Panel Distinguishes TB from Other Infections
RNA Sequencing of Nasal Samples Used to Diagnose Asthma
ELISA-Based Neonatal Screening Line Offers Menu of Eight Kits
High Vitamin D Levels Linked to Lower Cholesterol
MSI Tumor Analysis Implicates Lynch Syndrome in Cancer Types
Molecular Test Developed for Nasopharyngeal Carcinoma
RT-PCR Assay Developed to Detect Bloodstream Infections
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








